Filtered By:
Condition: Peripheral Vascular Disease (PVD)
Therapy: Statin Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 781 results found since Jan 2013.
Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases
Eur Heart J Cardiovasc Pharmacother. 2023 Aug 10:pvad059. doi: 10.1093/ehjcvp/pvad059. Online ahead of print.ABSTRACTAlthough bioinformatic methods gained a lot of attention in the latest years, their use in real-world studies for primary and secondary prevention of atherosclerotic cardiovascular diseases (ASCVD) is still lacking. Bioinformatic resources have been applied to thousands of individuals from the Framingham Heart Study as well as health care-associated biobanks such as the UK Biobank, the Million Veteran Program, and the CARDIoGRAMplusC4D Consortium and randomized controlled trials (i.e. ODYSSEY, FOURIER, ASPRE...
Source: Atherosclerosis - August 10, 2023 Category: Cardiology Authors: Giuditta Benincasa Rosa Suades Teresa Padr ò Lina Badimon Claudio Napoli Source Type: research
Peripheral Artery Disease: Treatment of Claudication and Surgical Management
Med Clin North Am. 2023 Sep;107(5):823-827. doi: 10.1016/j.mcna.2023.05.008. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an under-recognized and under-treated entity. Anti-platelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have pr...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Overview of Diagnosis and Medical Therapy
Med Clin North Am. 2023 Sep;107(5):807-822. doi: 10.1016/j.mcna.2023.05.007. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an underrecognized and undertreated entity. Antiplatelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have profo...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Treatment of Claudication and Surgical Management
Med Clin North Am. 2023 Sep;107(5):823-827. doi: 10.1016/j.mcna.2023.05.008. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an under-recognized and under-treated entity. Anti-platelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have pr...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Overview of Diagnosis and Medical Therapy
Med Clin North Am. 2023 Sep;107(5):807-822. doi: 10.1016/j.mcna.2023.05.007. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an underrecognized and undertreated entity. Antiplatelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have profo...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Treatment of Claudication and Surgical Management
Med Clin North Am. 2023 Sep;107(5):823-827. doi: 10.1016/j.mcna.2023.05.008. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an under-recognized and under-treated entity. Anti-platelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have pr...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Overview of Diagnosis and Medical Therapy
Med Clin North Am. 2023 Sep;107(5):807-822. doi: 10.1016/j.mcna.2023.05.007. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an underrecognized and undertreated entity. Antiplatelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have profo...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Treatment of Claudication and Surgical Management
Med Clin North Am. 2023 Sep;107(5):823-827. doi: 10.1016/j.mcna.2023.05.008. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an under-recognized and under-treated entity. Anti-platelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have pr...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Overview of Diagnosis and Medical Therapy
Med Clin North Am. 2023 Sep;107(5):807-822. doi: 10.1016/j.mcna.2023.05.007. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an underrecognized and undertreated entity. Antiplatelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have profo...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Treatment of Claudication and Surgical Management
Med Clin North Am. 2023 Sep;107(5):823-827. doi: 10.1016/j.mcna.2023.05.008. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an under-recognized and under-treated entity. Anti-platelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have pr...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Overview of Diagnosis and Medical Therapy
Med Clin North Am. 2023 Sep;107(5):807-822. doi: 10.1016/j.mcna.2023.05.007. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an underrecognized and undertreated entity. Antiplatelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have profo...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Treatment of Claudication and Surgical Management
Med Clin North Am. 2023 Sep;107(5):823-827. doi: 10.1016/j.mcna.2023.05.008. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an under-recognized and under-treated entity. Anti-platelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have pr...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
Peripheral Artery Disease: Overview of Diagnosis and Medical Therapy
Med Clin North Am. 2023 Sep;107(5):807-822. doi: 10.1016/j.mcna.2023.05.007. Epub 2023 Jul 3.ABSTRACTPeripheral artery disease (PAD) affects approximately 230 million people worldwide and is associated with an increased risk of major adverse cardiovascular and limb events. Even though this condition is considered a cardiovascular equivalent, it remains an underrecognized and undertreated entity. Antiplatelet and statin therapy, along with smoking cessation, are the foundations of therapy to reduce adverse events but are challenging to fully implement in this patient population. Race and socioeconomic status also have profo...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Matthew Bierowski Taki Galanis Amry Majeed Alireza Mofid Source Type: research
